Tech & Gadgets

Two AI-based science assistants succeed with drug-retargeting tasks

32 sec read337 views0 listens

Google and FutureHouse have introduced two agentic AI systems—Co-Scientist and a separate nonprofit project—designed to assist scientists with tasks like drug retargeting by processing vast amounts of biological data. This matters to developers and researchers because it highlights a shift toward AI tools that operate semi-autonomously using external tools, rather than just large language models, to accelerate hypothesis development. These systems are not built to replace scientists but rather to manage information overload, keeping human judgment central to the scientific process.

Read the full article at Ars Technica

Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.

You Might Like

Biotech & PharmaSep 1832 sec read

Two-Organ View of the Human Brain Emerges

New research indicates the human brain isn't a single organ, but rather two distinct nervous systems that evolved independently over hundreds of millions of years. This challenges a long-held developmental model and has significant implications for b...

Ali Nemati

Fitness & WellnessSep 1132 sec read

First Patient Implanted in US Post-Approval Study for Genio Sleep Apnea Therapy

A post-approval study, BREATHE, has begun enrolling patients to evaluate the long-term safety and effectiveness of a new leadless and battery-free hypoglossal nerve stimulation therapy for obstructive sleep apnea. This development is significant beca...

Ali Nemati

AI & Machine LearningSep 923 sec read

Man Announces That He Has Synthesized a New Schizophrenia Treatment in His Garage, Based on a Formula Devised by ChatGPT

A biochemist named Douglas Yao has synthesized a potential schizophrenia treatment called PAC-3310 in his garage, using a formula devised by AI model ChatGPT. This development highlights the growing role of AI in drug discovery but raises significant...

Ali Nemati